{"id":"https://openalex.org/W4245776345","doi":"https://doi.org/10.1146/annurev-med-070209-175325","title":"Multiple Myeloma","display_name":"Multiple Myeloma","alternate_titles":[],"publication_year":2010,"publication_date":"2010-01-26","ids":{"openalex":"https://openalex.org/W4245776345","doi":"https://doi.org/10.1146/annurev-med-070209-175325","pmid":"https://pubmed.ncbi.nlm.nih.gov/21090965"},"language":"en","primary_location":{"id":"doi:10.1146/annurev-med-070209-175325","doi":"https://doi.org/10.1146/annurev-med-070209-175325","is_oa":false,"landing_page_url":"https://doi.org/10.1146/annurev-med-070209-175325","pdf_url":null,"source":{"id":"https://openalex.org/S16909082","display_name":"Annual Review of Medicine","issn_l":"0066-4219","issn":["0066-4219","1545-326X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","medline","norway-1","poland-200","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320373","host_organization_name":"Annual Reviews","host_organization_lineage":["https://openalex.org/P4310320373"],"host_organization_lineage_names":["Annual Reviews"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annual Review of Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4245776345"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049711954","display_name":"Jacob P. Laubach","orcid":"https://orcid.org/0000-0001-7565-2052","observed_orcids":["https://orcid.org/0000-0001-7565-2052"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jacob Laubach","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, Massachusetts 02115;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, Massachusetts 02115;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043526996","display_name":"Paul Gerard Guy Richardson","orcid":"https://orcid.org/0000-0002-7426-8865","observed_orcids":["https://orcid.org/0000-0002-7426-8865"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul Richardson","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, Massachusetts 02115;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, Massachusetts 02115;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032464400","display_name":"Kenneth Carl Anderson","orcid":"https://orcid.org/0000-0002-6418-0886","observed_orcids":["https://orcid.org/0000-0002-6418-0886"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kenneth Anderson","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, Massachusetts 02115;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, Massachusetts 02115;","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210117453"],"apc_list":null,"apc_paid":null,"fwci":1.9933,"has_fulltext":false,"cited_by_count":161,"citation_normalized_percentile":{"value":0.87803086,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"62","issue":"1","first_page":"249","last_page":"264"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":1.0},{"id":"https://openalex.org/keywords/b-cell-malignancies","display_name":"B-cell malignancies","score":0.9459999799728394},{"id":"https://openalex.org/keywords/bone-marrow","display_name":"bone marrow","score":0.7210000157356262},{"id":"https://openalex.org/keywords/anemia","display_name":"anemia","score":0.7960000038146973},{"id":"https://openalex.org/keywords/bone-lesions","display_name":"bone lesions","score":0.8550000190734863},{"id":"https://openalex.org/keywords/hypercalcemia","display_name":"hypercalcemia","score":1.0},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.9959999918937683},{"id":"https://openalex.org/keywords/immunodeficiency","display_name":"immunodeficiency","score":0.7900000214576721},{"id":"https://openalex.org/keywords/plasma-cells","display_name":"plasma cells","score":0.8289999961853027},{"id":"https://openalex.org/keywords/pathogenesis","display_name":"pathogenesis","score":0.7239999771118164},{"id":"https://openalex.org/keywords/thalidomide","display_name":"thalidomide","score":0.8209999799728394},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":1.0},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.9179999828338623},{"id":"https://openalex.org/keywords/immunomodulators","display_name":"immunomodulators","score":0.9900000095367432},{"id":"https://openalex.org/keywords/diagnosis","display_name":"diagnosis","score":0.6389999985694885},{"id":"https://openalex.org/keywords/treatment","display_name":"treatment","score":0.9430000185966492}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8220189809799194},{"id":"https://openalex.org/C2779609412","wikidata":"https://www.wikidata.org/wiki/Q203174","display_name":"Thalidomide","level":3,"score":0.7810416221618652},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.7428157925605774},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.7162086963653564},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.6970297694206238},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.6823846101760864},{"id":"https://openalex.org/C2780942790","wikidata":"https://www.wikidata.org/wiki/Q372016","display_name":"Pathogenesis","level":2,"score":0.6458489894866943},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5455694794654846},{"id":"https://openalex.org/C2776396001","wikidata":"https://www.wikidata.org/wiki/Q250694","display_name":"Plasma cell","level":3,"score":0.5321577787399292},{"id":"https://openalex.org/C2778367456","wikidata":"https://www.wikidata.org/wiki/Q7251235","display_name":"Proteasome inhibitor","level":3,"score":0.45330724120140076},{"id":"https://openalex.org/C2780525284","wikidata":"https://www.wikidata.org/wiki/Q7882181","display_name":"Bone marrow failure","level":4,"score":0.42258933186531067},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3577702045440674},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34479260444641113},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.10426470637321472},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.09321442246437073},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069286","descriptor_name":"Bortezomib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077269","descriptor_name":"Lenalidomide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000740","descriptor_name":"Anemia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D001847","descriptor_name":"Bone Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D001897","descriptor_name":"Boronic Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006934","descriptor_name":"Hypercalcemia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010523","descriptor_name":"Peripheral Nervous System Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015853","descriptor_name":"Cysteine Proteinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D033581","descriptor_name":"Stem Cell Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051437","descriptor_name":"Renal Insufficiency","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D061988","descriptor_name":"Proteasome Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1146/annurev-med-070209-175325","doi":"https://doi.org/10.1146/annurev-med-070209-175325","is_oa":false,"landing_page_url":"https://doi.org/10.1146/annurev-med-070209-175325","pdf_url":null,"source":{"id":"https://openalex.org/S16909082","display_name":"Annual Review of Medicine","issn_l":"0066-4219","issn":["0066-4219","1545-326X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","medline","norway-1","poland-200","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320373","host_organization_name":"Annual Reviews","host_organization_lineage":["https://openalex.org/P4310320373"],"host_organization_lineage_names":["Annual Reviews"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annual Review of Medicine","raw_type":"journal-article"},{"id":"pmid:21090965","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21090965","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annual review of medicine","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":93,"referenced_works":["https://openalex.org/W29171763","https://openalex.org/W78595991","https://openalex.org/W90424273","https://openalex.org/W226917763","https://openalex.org/W1817229679","https://openalex.org/W1905293247","https://openalex.org/W1932993947","https://openalex.org/W1959587708","https://openalex.org/W1969486712","https://openalex.org/W1970008554","https://openalex.org/W1971199955","https://openalex.org/W1971353106","https://openalex.org/W1971494282","https://openalex.org/W1972249638","https://openalex.org/W1974983065","https://openalex.org/W1978377409","https://openalex.org/W1985147506","https://openalex.org/W1985949282","https://openalex.org/W1986501999","https://openalex.org/W1988605844","https://openalex.org/W1991206717","https://openalex.org/W1992538067","https://openalex.org/W1996560056","https://openalex.org/W1997001746","https://openalex.org/W1999077925","https://openalex.org/W2000655497","https://openalex.org/W2006382315","https://openalex.org/W2010552629","https://openalex.org/W2010977839","https://openalex.org/W2019336481","https://openalex.org/W2019612632","https://openalex.org/W2021954218","https://openalex.org/W2026295989","https://openalex.org/W2026716861","https://openalex.org/W2030894550","https://openalex.org/W2031157863","https://openalex.org/W2034031119","https://openalex.org/W2038329170","https://openalex.org/W2044436186","https://openalex.org/W2045752069","https://openalex.org/W2046344984","https://openalex.org/W2049869153","https://openalex.org/W2051862080","https://openalex.org/W2053166134","https://openalex.org/W2053456304","https://openalex.org/W2053784212","https://openalex.org/W2057034336","https://openalex.org/W2066800926","https://openalex.org/W2073075677","https://openalex.org/W2073370692","https://openalex.org/W2075092656","https://openalex.org/W2082853777","https://openalex.org/W2087843841","https://openalex.org/W2094425590","https://openalex.org/W2095194399","https://openalex.org/W2096207943","https://openalex.org/W2101995865","https://openalex.org/W2104148554","https://openalex.org/W2104452168","https://openalex.org/W2106838577","https://openalex.org/W2115015071","https://openalex.org/W2115385885","https://openalex.org/W2117172636","https://openalex.org/W2118820477","https://openalex.org/W2120400738","https://openalex.org/W2120474651","https://openalex.org/W2124240218","https://openalex.org/W2124560610","https://openalex.org/W2126116268","https://openalex.org/W2127761209","https://openalex.org/W2127846055","https://openalex.org/W2140056608","https://openalex.org/W2146502962","https://openalex.org/W2148188974","https://openalex.org/W2150997370","https://openalex.org/W2154374454","https://openalex.org/W2155165473","https://openalex.org/W2157423336","https://openalex.org/W2160088903","https://openalex.org/W2164807675","https://openalex.org/W2165574508","https://openalex.org/W2166508172","https://openalex.org/W2240274733","https://openalex.org/W2264313156","https://openalex.org/W2316160054","https://openalex.org/W2325302070","https://openalex.org/W2333363976","https://openalex.org/W2335826340","https://openalex.org/W2337879364","https://openalex.org/W3023358503","https://openalex.org/W4241442958","https://openalex.org/W4256283411","https://openalex.org/W4317676163"],"related_works":["https://openalex.org/W2136640056","https://openalex.org/W4386790694","https://openalex.org/W1567069285","https://openalex.org/W63410511","https://openalex.org/W6912271576","https://openalex.org/W2904231094","https://openalex.org/W4233547745","https://openalex.org/W2509229296","https://openalex.org/W1590836620","https://openalex.org/W4240207740"],"abstract_inverted_index":{"Multiple":[0],"myeloma":[1],"(MM)":[2],"is":[3,55],"a":[4,13],"B":[5],"cell":[6],"neoplasm":[7],"of":[8,16,34,40,45,53,60,75,95,102,138,146,152,157],"the":[9,46,58,65,80,100,111,117,136,141,147],"bone":[10,21,49,66],"marrow":[11,67],"with":[12,73],"complex":[14],"array":[15],"clinical":[17,144],"manifestations":[18,145],"including":[19],"anemia,":[20],"lesions,":[22],"hypercalcemia,":[23],"renal":[24],"dysfunction,":[25],"and":[26,38,48,89,98,104,115,121,143,149,155],"compromised":[27],"immune":[28],"function.":[29],"It":[30],"accounts":[31],"for":[32],"10%-15%":[33],"all":[35],"hematologic":[36],"malignancies,":[37],"20%":[39],"deaths":[41],"related":[42],"to":[43],"cancers":[44],"blood":[47],"marrow.":[50],"The":[51],"diagnosis":[52,154],"MM":[54],"based":[56],"on":[57],"presence":[59],"neoplastic":[61],"plasma":[62],"cells":[63],"in":[64,86,135],"or":[68],"other":[69,122],"extramedullary":[70],"sites,":[71],"along":[72],"evidence":[74],"disease-related":[76],"organ":[77],"dysfunction.":[78],"Although":[79],"disease":[81,96],"remains":[82],"incurable,":[83],"significant":[84],"advances":[85],"both":[87,153],"basic":[88],"translational":[90],"research":[91],"have":[92],"enhanced":[93],"understanding":[94],"pathogenesis":[97,142],"guided":[99],"development":[101],"new":[103],"more":[105],"effective":[106],"therapies.":[107],"These":[108],"agents":[109],"include":[110],"immunomodulatory":[112],"drugs":[113],"thalidomide":[114],"lenalidomide,":[116],"proteasome":[118],"inhibitor":[119],"bortezomib,":[120],"therapeutics":[123],"that":[124],"are":[125],"currently":[126],"being":[127],"evaluated.":[128],"This":[129],"review":[130],"highlights":[131],"important":[132],"historical":[133],"landmarks":[134],"field":[137],"MM,":[139],"examines":[140],"disease,":[148],"outlines":[150],"principles":[151],"treatment":[156],"MM.":[158]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4245776345","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":15},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":17},{"year":2012,"cited_by_count":21}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2022-05-12T00:00:00"}
